Celldex Therapeutics Inc
F:TCE2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
Daiwa House Industry Co Ltd
F:DWH
|
JP |
|
S
|
State Street Corp
XMUN:ZYA
|
US |
|
Siemens AG
MIL:1SIE
|
DE |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
I
|
IAMGOLD Corp
F:IAL
|
CA |
|
F
|
Frontline Ltd
F:FRLN
|
BM |
|
Sino-Platinum Metals Co Ltd
SSE:600459
|
CN |
|
T
|
Turning Point Brands Inc
F:0T5
|
US |
|
U
|
Unum Group
F:UUM
|
US |
|
I
|
Impala Platinum Holdings Ltd
XMUN:IPHB
|
ZA |
|
P
|
Phunware Inc
F:2RJ
|
US |
|
K
|
Konami Holdings Corp
F:KOA
|
JP |
|
B
|
Baidu Inc
F:B1C
|
CN |
|
I
|
ITV PLC
XMUN:IJ7
|
UK |
|
S
|
Salesforce Inc
DUS:FOO
|
US |
|
S
|
Siemens AG
SWB:SIE
|
DE |
|
K
|
Kingspan Group PLC
DUS:KRX
|
IE |
|
W
|
WP Carey Inc
F:WPY
|
US |
|
G
|
General Electric Co
SIX:GE
|
US |
|
C
|
CBRE Group Inc
DUS:RF6
|
US |
|
K
|
Kawasaki Heavy Industries Ltd
XMUN:KHE
|
JP |
|
S
|
Siemens AG
XBER:SIE
|
DE |
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
3.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
